eye treatment biosimilar
Scope
Date
~
-
Bio & Pharma
Celltrion applies for approval in US for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. on Friday said it applied for approval from the US Food and Drug Administration (FDA) for CT-P...
Jun 30, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
SK E&S eyes business split-up to raise up to $1. 5 bn
South Korea’s SK E&S Co. is seeking to split up its business to raise up to 2 trillion won ($1.5 billion), according to people with knowle...
Jun 29, 2023 (Gmt+09:00)
-
Automobiles
Hyundai bets big on futuristic displays, eyes roll-up screen in 3 years
South Korea’s top auto parts maker Hyundai Mobis Co. said on Tuesday it expects to begin mass production of its rollable vehicle display &ndas...
Jun 27, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Chemicals, AZ mark first commercial production of diabetes drugs
South Korea's SK Chemicals has joined forces with global pharmaceutical firm AstraZeneca to initiate commercial production of a chemical drug for di...
Jun 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion puts Takeda’s assets up for sale after 3 years
South Korea’s Celltrion Inc. has put its Japanese Takeda Pharmaceutical Co.'s primary care assets acquired in 2020 on sale as the biosimilar g...
Jun 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Daehwa Pharm applies for approval of anti-dementia patch in China
South Korea's Daehwa Pharm Co. is speeding up its advance into the Chinese market for anti-dementia medicine, applying for sales approval of its pat...
Jun 16, 2023 (Gmt+09:00)
-
Robotics
POSCO targets robotic automation solutions for new growth
SEONGNAM, Gyeonggi Province -- POSCO DX Co., the IT services subsidiary of South Korea’s largest steelmaker POSCO Group, aims to enter the rob...
Jun 15, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm’s Cenobamate gets nod in Canada, to boost US sales
South Korea’s SK Biopharmaceuticals Co. has obtained the sales approval for its antiepileptic treatment Cenobamate in Canada, paving the way f...
Jun 15, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins phase 3 IND approval for Ocrevus biosimilar in US
South Korea's biopharmaceutical company Celltrion Inc. announced that it received on Thursday approval from the US Food and Drug Administration (FDA...
Jun 15, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion to expand biosimilar portfolio to 11 by 2025
South Korea's biopharmaceutical company Celltrion Inc. announced on Tuesday that it plans to beef up its portfolio by applying for regulatory approv...
Jun 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis to enhance biosimilar presence with Epysqli
FRANKFURT – Samsung Bioepis Co., a biopharmaceutical unit of South Korea’s top conglomerate Samsung, is looking to gain ground in the ra...
Jun 12, 2023 (Gmt+09:00)
-
Artificial intelligence
OpenAI’s Sam Altman seeks help from Korean startups, chipmakers
Sam Altman, chief executive of Microsoft-backed OpenAI and ChatGPT creator, said on Friday that he hopes to collaborate with South Korean developers...
Jun 09, 2023 (Gmt+09:00)
-
Electronics
LG Electronics eyes premium market in Saudi Arabia, India
LG Electronics Inc. will seek out new business opportunities as a premium brand in Saudi Arabia for the oil-rich kingdom’s $500 billion Neom m...
Jun 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics to double production by 2032; eyes ADCs, M&As
BOSTON – Samsung Biologics Co., the world’s No. 1 contract drugmaker, plans to more than double its total annual production capacity to ...
Jun 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion to develop Humira biosimilar oral medication with US firm
South Korea's biopharmaceutical company Celltrion Inc. announced on Monday that it has signed a contract with the US biotech firm Rani Therapeutics ...
Jun 05, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Remsima SC praised in Europe as preferred biosimilar
MILAN – South Korea's biopharmaceutical company Celltrion Inc. is known in Europe for its biosimilar products such as autoimmune disease treat...
Jun 02, 2023 (Gmt+09:00)
-
Venture capital
SK Networks eyes partnership with US-based Bow Capital
SK Networks Co., a South Korean trading company, is seeking to form a partnership with Silicon Valley-based venture capital firm Bow Capital to dive...
May 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion unveils phase 1 clinical data of Actemra biosimilar in Europe
South Korean biosimilar giant Celltrion Inc. revealed on Wednesday the highly anticipated clinical phase 1 data for its Actemra biosimilar, CT-P47, ...
May 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis gets approval to sell biosimilar in Europe
South Korea's Samsung Bioepis has received approval in Europe to sell a biosimilar of Soliris, a drug for the treatment of adult and children patien...
May 31, 2023 (Gmt+09:00)
-
Airlines
Air Busan targets record profit with more int’l flights
Air Busan Co., a South Korean low-cost carrier, targets record earnings with more international flights, especially to neighboring China and Japan, ...
May 30, 2023 (Gmt+09:00)
-
Bio & Pharma
HanAll, Daewoong to develop Parkinson's treatment with US partner
South Korea's HanAll Biopharma Co. and Daewoong Pharmaceutical on Thursday said they concluded a contract with NurrOn Pharmaceuticals of the US on...
May 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets FDA approval for Humira biosimilar CT-P17
South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has obtained product approval from the US Food and Drug Adminis...
May 24, 2023 (Gmt+09:00)
-
Artificial intelligence
Neurophet strives to be first mover in fight against Alzheimer’s
Neurophet Inc., a South Korean startup developing artificial intelligence-powered medical solutions for brain diseases, is striving to make a breakt...
May 24, 2023 (Gmt+09:00)
-
Aerospace & Defense
Hanwha aims to develop unmanned fighter jet engine within decade
Hanwha Aerospace Co., South Korea’s answer to Elon Musk’s SpaceX, aims to develop engines for unmanned aircraft within the next decade t...
May 24, 2023 (Gmt+09:00)
-
Korean SMEs
Boeing-backed Huneed eyes civil aircraft market beyond jets
South Korea’s Huneed Technologies specializes in aircraft components such as military communications equipment and supplies them to the armed ...
May 23, 2023 (Gmt+09:00)
-
Business & Politics
S.Korea business lobby group regrets past political role
The Federation of Korean Industries (FKI) on Thursday said it deeply regretted the political role it took in the previous governments and vowed to b...
May 18, 2023 (Gmt+09:00)
-
Artificial intelligence
Korean institutions eye investment in OpenAI at $40 bn valuation
OpenAI, the world’s most well-known artificial intelligence lab, is tapping South Korean institutional investors for investment at an estimate...
May 17, 2023 (Gmt+09:00)
-
Electric vehicles
Hyundai to invest $2.45 bn in India, eyes spot in global EV top 3
South Korea’s top automaker Hyundai Motor Co. will invest 200 billion rupees ($2.45 billion) in the Indian state of Tamil Nadu over the next d...
May 12, 2023 (Gmt+09:00)
-
Earnings
Lotte Chemical projects recovery in Q2 after 4th consecutive loss in Q1
Lotte Chemical Corp. suffered its fourth consecutive operating loss in the first quarter due to a prolonged petrochemical slowdown amid the global e...
May 11, 2023 (Gmt+09:00)
-
Business & Politics
US eyes new rules for Samsung, SK to bring chip machines to China
The US government is considering establishing new rules for South Korea’s chipmakers to import advanced equipment to China to upgrade their fa...
May 10, 2023 (Gmt+09:00)
Latest News
- 1 BMW surpasses Mercedes in Korean sales amid imported vehicle market shake-up
- 2 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 3 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 4 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 5 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google